Načítá se...
Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma
Nivolumab is a programmed death receptor 1 (PD-1) inhibitor. It is part of a group of drugs known as immune checkpoint blockers, which enable potent and durable T-cell responses against several tumors. We report the case of a patient with a metastatic squamous cell carcinoma, who is being treated wi...
Uloženo v:
| Vydáno v: | Case Rep Dermatol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
S. Karger AG
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7315375/ https://ncbi.nlm.nih.gov/pubmed/32595466 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000505478 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|